Semaglutide versus dulaglutide once weekly in patients with type 2 diabetes (SUSTAIN 7): a randomised, open-label, phase 3b trial Article

ESI Most Cited Paper International Collaboration

cited authors

  • Pratley, Richard E.; Aroda, Vanita R.; Lingvay, Ildiko; Luedemann, Jorg; Andreassen, Camilla; Navarria, Andrea; Viljoen, Adie; Sustain 7 Investigators

authors

Publication Date

  • April 1, 2018

webpage

published in

category

start page

  • 275

end page

  • 286

volume

  • 6

issue

  • 4